Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
TwitterLinkedinFacebookFeed
Technology Appraisal Conflict of Interest Policy

I.    ICER has been purposely structured as a fully transparent organization that is able to engage with all key stakeholders in its appraisals while retaining complete independence in the formulation of its conclusions and the drafting of its reviews.  

 

II.    The ICER technology appraisal process explicitly seeks to include the perspectives and input of stakeholders who have extensive knowledge of the technology and the field of medicine.  ICER therefore includes on its Evidence Review Groups manufacturers, clinical experts, public and private insurer medical policy leaders, and patients.  These stakeholders will have a wide range of potential influences on their judgment, including financial conflicts of interest, reputational concerns, and personal or family experiences with the technology or its comparators. 

III.    ICER’s policy will be to require full disclosure of all potential influences of judgment within the participants of its Evidence Review Groups.  There will be no threshold for potential influences on judgment: all potential influences, no matter how “small,” must be disclosed.   This requirement for full disclosure will be made clear to prospective participants in an Evidence Review Group before they are accepted as a member.  The disclosure itself will be made public as an integral part of ICER appraisal documents.

IV.    There will be no threshold of potential influences on judgment that will require the recusal of a member of any Evidence Review Group.

V.    This policy of full disclosure of all potential influences on judgment extends to all ICER staff involved in the appraisal and will also be made part of the public record within the ICER appraisal documents.

VI.    Because of the inclusive design of ICER Evidence Review Groups, the advice, comments, and any votes taken by members of Evidence Review Groups will be viewed as solely advisory in nature to ICER and will not in any way be dispositive.  Narrative elements of ICER appraisal documents will record the deliberation of Evidence Review Groups and portray explicitly and transparently the individual source(s) of comments and perspectives.